NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

AlphaGrep Receives Mutual Fund Licence from SEBI

AlphaGrep, a global quantitative trading and investment firm, has received a mutual fund licence from the Securities and Exchange Board of India (SEBI). This development marks a significant milestone for the firm, which has evolved from a boutique quantitative trading desk since its founding in 2010.

As of February 2026, AlphaGrep manages over Rs 8,500-crore in assets, making it one of the largest participants by trading volume on domestic exchanges. The firm aims to bring data science-driven investment strategies to retail investors through the launch of AlphaGrep Mutual Fund, offering access to systematic investment tools previously limited to institutional investors and ultra-high-net-worth individuals.

The MF business will operate under AlphaGrep Investment Management Pvt Ltd (AGIM), which already manages Rs 2,000 crore in assets through its alternative investment fund (AIF) and portfolio management services (PMS) platforms, including operations in GIFT City. The new MF platform will focus on quantitative equity and hybrid strategies, utilizing advanced mathematical models along with artificial intelligence and machine learning.

Read also: Groww AMC Secures Strategic Boost as SEBI Approves State Street Global Advisors' Minority Stake

Bhautik Ambani, Chief Executive Officer of AlphaGrep Investment Management, will lead the MF business. The firm plans to launch its first New Fund Offers (NFOs) in the coming months, focusing on systematic equity strategies and rules-based hybrid investment products.

Investor Takeaway

Investors should consider AlphaGrep's mutual fund offerings for data science-driven investment strategies.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.